Hashizume A

ORCID: 0009-0008-1054-0779 · 2 papers in corpus

observational 2026

Fewer Injections and Lower Drug Costs With Long-Acting GnRH Depot Formulations: A Nationwide Analysis of 2.3 Million Patient-Years in Japan

Cancer reports (Hoboken, N.J.) ·doi:10.1002/cnr2.70688

BACKGROUND: Androgen deprivation therapy (ADT) is the base of treatment for prostate cancer, and gonadotropin-releasing hormone (GnRH) drugs are given as depot injections. Long-acting formulations may reduce the number of injections and the…

other 2012

The utility of serum N-ERC/mesothelin as a biomarker of ovarian carcinoma

Oncology letters ·doi:10.3892/ol.2012.796

Ovarian carcinoma has been difficult to diagnose at an early stage. Recently, it has been recognized that the measurement of blood N-ERC/mesothelin levels aids early detection in and postoperative therapeutic monitoring of patients with mes…